MaxCyte | IPO Presentation Deck | 34 slides

MaxCyte · 2021-07
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

34
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
This is a standard financial offering summary slide for an IPO or follow-on offering.other
04
summarize
Open slide detailLoop · Golden Circle
05
The slide is split into two main sections: Executive Leadership (left) and Board of Directors (right), with a column of company logos on the far right.other
Open slide detailLoop · Golden Circle
06
The slide uses a growth curve to represent 'Impact' over time, highlighting both product development and corporate milestones.show_traction
Open slide detailLoop · Golden Circle
07
The slide uses a funnel-like process diagram to illustrate business development success.show_traction
Open slide detailBeat · Traction
08
The slide uses a dual-ring donut chart visualization to compare internal partner data against the external market.show_traction
Open slide detailBeat · Traction
09
size_opportunity
Open slide detailBeat · Problem
10
Uses a before-after-bridge style framing to connect pain points to product benefits.present_solution
Open slide detailBeat · Problem
11
The slide uses a vertical process-like flow to map platform benefits to specific instrument categories.present_solution
Open slide detailBeat · Solution
12
The slide highlights two distinct business segments with specific revenue streams for each.present_solution
Open slide detailBeat · Solution
13
The chart is a growth curve showing the accumulation of partner logos over time, culminating in a milestone value of >$950m USD.show_traction
14
The slide uses a stacked area chart to visualize revenue growth over time, annotated with specific clinical development phases.present_solution
15
The slide uses a mix of horizontal bar charts, a stacked bar chart, a big number metric, and a pie chart to demonstrate consistent growth.show_traction
Open slide detailBeat · Financials
16
The slide uses a process flow diagram to illustrate the manufacturing steps, with QC and EBR checkpoints.summarize
Open slide detailBeat · Financials
17
The slide uses a chevron-based list format to highlight four distinct pillars of the investment thesis.summarize
18
Standard corporate closing slide with branding and copyright.state_next_steps
20
The slide uses a 4-step process diagram to illustrate the mechanism of action for electroporation.establish_context
21
The slide uses a comparison table to frame the company's technology against competitors in the non-viral delivery space.compare_peers
Open slide detailLoop · Cost Of Inaction
22
The slide uses a timeline-based process flow to map product usage and commercial terms across the development lifecycle.plan_implementation
Open slide detailLoop · Cost Of Inaction
23
Shows a transition from current beta testing to future ExPERT brand launch.present_solution
Open slide detailLoop · Cost Of Inaction
24
The diagram uses a hub-and-spoke model to centralize 'Platform IP' as the core, surrounded by supporting IP categories.present_framework
25
Highlights regulatory efficiency as a competitive moat.present_solution
26
The chart shows 40% captured and 15% in discussions, totaling 55% potential market share.show_traction
27
The slide uses a structured layout to demonstrate the breadth of the technology's capabilities.present_solution
28
The chart uses a stacked bar format to show the composition of programs across Preclinical, Clinical, and Commercial stages.size_opportunity
Open slide detailBeat · Why Now
29
transition
Open slide detailBeat · Why Now
30
Data sourced from Kagita et al., Stem Cell Reports, April 2021.compare_peers
Open slide detailLoop · Quick Win Big Bet
31
Includes both internal validation data (left) and external customer-generated data (right).show_traction
Open slide detailLoop · Quick Win Big Bet
32
Comparison of OC-100 and R-1000 processing assemblies.show_traction
Open slide detailLoop · Quick Win Big Bet
33
The slide highlights a specific clinical trial outcome (Phase 1) and provides a process timeline alongside a data table.show_traction
34
The slide uses a timeline diagram to visually contrast the speed of the two methods.compare_peers